Results 161 to 170 of about 250,513 (342)

Newcastle disease virus as an antineoplastic agent [PDF]

open access: bronze, 1965
William A. Cassel, R. Earl Garrett
openalex   +1 more source

An Exploration of the High Prevalence of Parkinson's Disease in a Rural Area of North West England

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Globally the prevalence of Idiopathic Parkinson's Disease (IPD) is rising. Increasing recognition is being given to the influence of environmental factors on this rise, although the precise impact of such factors remains poorly understood.
Rosanna Varden   +2 more
wiley   +1 more source

Contralateral Spread of Asymmetrical Tremor in Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinsonian tremor usually starts asymmetrically. The mid‐term prognosis of this lateralized tremor is unknown, as is the development of tremor in the contralateral arm. Objective To investigate the occurrence of contralateral tremor in the Parkinson's Progression Marker Initiative database, with data available for 7 years ...
Jacopo Pasquini   +4 more
wiley   +1 more source

Interferon Production by Inactivated Newcastle Disease Virus in Cell Cultures and in Mice [PDF]

open access: bronze, 1966
Julius S. Youngner   +3 more
openalex   +1 more source

Is there a preference for PET or SPECT brain imaging in diagnosing dementia? The views of people with dementia, carers, and healthy controls [PDF]

open access: yes, 2016
Cam Donaldson   +10 more
core   +1 more source

Brain Networks Route Neurodegeneration Patterns in Patients with Progressive Supranuclear Palsy

open access: yesMovement Disorders, EarlyView.
Abstract Background Progressive supranuclear palsy (PSP) is a neurodegenerative disease driven by 4‐repeat τ pathology, which is thought to propagate across interconnected neurons. Objectives We hypothesized that interconnected brain regions exhibit correlated atrophy, and that atrophy propagates network‐like from fast‐declining epicenters to connected
Carla Palleis   +183 more
wiley   +1 more source

Avian sciences research update: Newcastle disease research

open access: yesCalifornia Agriculture, 1978
California Agriculture - All ...
R Bankowski
doaj  

Brain Atrophy Does Not Predict Clinical Progression in Progressive Supranuclear Palsy

open access: yesMovement Disorders, EarlyView.
Abstract Background Clinical progression rate is the typical primary endpoint measure in progressive supranuclear palsy (PSP) clinical trials. Objectives This longitudinal multicohort study investigated whether baseline clinical severity and regional brain atrophy could predict clinical progression in PSP–Richardson's syndrome (PSP‐RS).
Andrea Quattrone   +424 more
wiley   +1 more source

Home - About - Disclaimer - Privacy